Laurus Labs shifts gears as CDMO emerges as key growth driver; Nuvama sees 24% upsideNuvama Institutional Equities has initiated coverage on Laurus Labs with a ‘Buy’ rating and a target price of Rs 2,520, implying a 24% upsi...
16 Oct, 2026, 03.22 PM IST
Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improveLaurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The...
26 Jun, 2026, 06.37 AM IST
Buy, Sell or Hold: Antique maintains Hold on Laurus Labs; Motilal Oswal remains Neutral on Tata ChemicalsBrokerage firms shared mixed views on Laurus Labs, Tata Chemicals, and Kotak Mahindra Bank. Antique maintained a 'Hold' on Laurus despite r...
28 Jul, 2025, 09.42 AM IST
Remain fairly positive, market unlikely to fall; betting on largecaps: Rajat SharmaMarket expert Rajat Sharma favors large-cap stocks. He is buying Infosys, ITC, and HUL. Sharma also likes Laurus Labs and Tata Power. He se...
06 Dec, 2024, 08.11 AM IST
Goldman picks 2 pharma stocks, screams sells on Laurus LabsGoldman Sachs' ratings triggered price movements, with Syngene and Neuland rising but Laurus falling. Syngene is set to benefit from China+...
12 Apr, 2024, 11.25 AM IST
Q4 results today: Laurus Labs, Indian Hotels, Glenmark Life, Motilal OswalLaurus Labs' net profit fell 55% to Rs 103 crore in Q4 2021, with revenues declining by a marginal 3% to Rs 1,381 crore. Glenmark Life's pr...
27 Apr, 2023, 07.41 PM IST
Hot Stocks: Brokerages on Laurus Labs, Tata Motors, SRF, L&T, and PNBMorgan Stanley maintained an Equal-Weight rating on PNB post December quarter results with a target price of Rs 60. The global investment b...
31 Jan, 2023, 11.05 AM IST
What to look for if you are betting on the capex theme? Gurmeet Chadha answers“We are seeing opportunity in chemicals and in EMS. The industry can grow from $75 million to $300 million. In fact there is a note that ou...
20 Oct, 2022, 09.34 AM IST
Laurus Labs posts Rs 251 crore net profit in Q1FY23The company attributed this to the change in the effective tax rate for Q1FY23 on account of a drop in SEZ profits exemption u/s 10AA to 50...
27 Jul, 2022, 06.54 PM IST
How Laurus Labs capex drive can impact its margins & valuationsRise in headwinds in the pharma industry due to inflation, increase in raw material costs, and excessive competition led to price erosion i...
13 Jul, 2022, 12.37 PM IST
Jefferies sees up to 21% upside in these two pharma stocksIt has a target of Rs 4,566 on Gland Pharma, valuing the stock at 36.5 times FY24 EPS, in line with its historical one-year forward of 37 t...
05 Jan, 2022, 10.57 AM IST
Want to bet on the digital wave? Ravi Dharamshi tells you how“For now, we have to go after the “shovel sellers” or the enablers of this opportunity which is still unfolding; the technology is still ev...
01 Aug, 2021, 09.01 AM IST
Laurus Labs Q3 results: Net profit zooms nearly 4-fold to Rs 273 crThe company had posted a net profit of Rs 73.47 crore for the corresponding period of the previous fiscal, Laurus Labs said in a filing to ...
28 Jan, 2021, 05.28 PM IST
Q1 net more than annual profit! This API maker is creating a splash on Dalal StreetAPIs are active pharma ingredients used to make drugs, while formulation is the process where APIs are used in specific ratios to produce a...
03 Aug, 2020, 01.28 PM IST
Buy Laurus Lab, target price Rs 623: AmbitThere is high medium-term growth visibility and R&D spend commercialization would drive FY22 P/E re-rating from 13 times to 18 times on the...
24 Mar, 2020, 10.36 AM IST
Buy Laurus Labs, target Rs 470: Motilal Oswal SecuritiesBuy Laurus Labs at a price target of Rs 470.
11 Apr, 2019, 01.49 PM IST
Lauras Labs’ Q2 net up 1% on higher capexFor the quarter ended September 2017, the company posted a 4.3% growth in its revenues to Rs 538.6 crore as against Rs 516.5 crore in the c...
10 Nov, 2017, 09.49 PM IST